- Investing Ideas
- /
- German Pharmaceuticals & Biotech Growth at Reasonable Price
German Pharmaceuticals & Biotech Growth at Reasonable Price
Results
2
0 new
2 companies
Gerresheimer
Market Cap: €1.6b
Manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally.
GXI
€45.54
7D
2.3%
1Y
-52.9%
Evotec
Market Cap: €1.2b
Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.
EVT
€6.58
7D
-1.8%
1Y
10.8%